Clinical Machine Learning Researcher
University of Oxford
Dr. Andrew P. Creagh is currently a Postdoctoral Researcher at the Computational Health Informatics (CHI) laboratory, Institute of Biomedical Engineering (IBME), at the University of Oxford. He is concurrently a Junior Research Fellow at St. Cross College, University of Oxford and a Postdoctoral Fellow at GSK, London.
Andrew obtained a DPhil. (PhD) in Clinical Machine Learning from the University of Oxford, for his work developing digital biomarkers in collaboration with pharmaceutical partners, F. Hoffmann-La Roche. Previously, Andrew was awarded his bachelor’s degrees (BAI, BA) and Master’s degree (MAI) in Biomedical Engineering from Trinity College, the University of Dublin.
Andrew’s research aims to explore how “digital biomarkers” of disease can be captured for people who have neurodegenerative and autoimmune conditions, through continuously collecting smartphone and smartwatch measurements from patients at home. Transforming these data streams though advanced machine- and deep-learning techniques enable the learning of complex and unseen digital patterns of disease, to help remotely monitor and identify signs of degeneration before they occur, and ultimately to create innovative ways to further drug discovery and better treatment regimes.